Introduction of new products and stronger growth are anticipated in
WEST CHESTER, Ohio--(BUSINESS WIRE)--
AtriCure, Inc. (Nasdaq: ATRC) and Century Medical, Inc. (CMI) of Japan
announce the extension and expansion of their multi-year agreement in
which CMI will distribute AtriCure’s surgical ablation technologies to
hospitals in Japan. AtriCure is a medical device company and leader in
cardiac surgical ablation systems for the treatment of Afib and systems
for the exclusion of the left atrial appendage.
The new agreement provides CMI with exclusive rights to market the
AtriCure product lines, including future sales of the AtriClip Left
Atrial Appendage Exclusion System once formal approval processes are
completed by CMI. The AtriClip is one of the fastest growing segments of
the overall AtriCure portfolio worldwide. This agreement marks the first
time the products will be available in Japan.
“We are very excited about solidifying and expanding a long-term
relationship with a team so talented, experienced and knowledgeable in
our products,” said Michael Carrel, President and CEO of AtriCure. “This
agreement sets a strong foundation in the Japanese market for many years
According to the agreement, CMI will be the exclusive distributor of
AtriCure devices for Japan until 2019, with minimum revenue commitments
set forth over the next three years.
“We’re pleased to continue our partnership with AtriCure, and provide
the people of Japan life-changing treatment tools for use in soft tissue
ablation. With the opportunity to use AtriCure devices increasing in
Japan, our partnership has the potential to benefit hundreds of
thousands of people,” said Akira Hoshino, president and CEO of CMI.
About Century Medical
Medical, Inc. (CMI) is a wholly owned subsidiary of Itochu Corporation
(“ITOCY”-OTCYMKTS) and one of the largest Japanese general trading
companies with $125 billion in annual trading transactions. CMI has more
than 300 employees, offices in seven major cities in Japan and 39 years’
experience marketing medical devices in Japan. CMI has been a pioneering
force successfully introducing many new technologies to the Japanese
healthcare community and has built a dedicated team of 40 sales and
marketing people to serve the Japanese cardiovascular surgery community.